MIAT and ovarian carcinoma: Among these m6A-related eRNAs in the risk model, MIAT has been reported as a carcinogenic agent in a variety of tumors (such as gastric cancer, hepatocellular carcinoma, colorectal cancer, ovarian cancer, breast cancer, etc.).